Who makes Corsodyl Original Dentifrice?

Corsodyl Original Dentifrice is developed by HALEON.

What development phase is Corsodyl Original Dentifrice in?

Corsodyl Original Dentifrice is in Phase 1.

What are the side effects of Corsodyl Original Dentifrice?

Common side effects include GINGIVAL INJURY, GINGIVAL BLEEDING, TOOTHACHE, VOMITING, MIGRAINE.

Last reviewed 2026-04-20 · How we verify

Corsodyl Original Dentifrice

HALEON · Phase 1 active Small molecule Quality 5/100

At a glance

Generic name	Corsodyl Original Dentifrice
Sponsor	HALEON
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

GINGIVAL INJURY
GINGIVAL BLEEDING
TOOTHACHE
VOMITING
MIGRAINE

Key clinical trials

A Clinical Study Investigating the Effects of a Dentifrice Containing 67% Sodium Bicarbonate When Used Twice Daily for 12 Weeks on Gingivitis Treatment and Plaque Removal (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Corsodyl Original Dentifrice CI brief — competitive landscape report
Corsodyl Original Dentifrice updates RSS · CI watch RSS
HALEON portfolio CI